Therapeutic Potential of N-Acetyl-Glucagon-Like Peptide-1 in Primary Motor Neuron Cultures Derived From Non-Transgenic and SOD1-G93A ALS Mice
Authors:
- 28 December 2012
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 33 (3) , 347-357
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the death of motor neurons (MN) in the motor cortex, brain stem, and spinal cord. In the present study, we established an ALS in vitro model of purified embryonic MNs, derived from non-transgenic and mutant SOD1-G93A transgenic mice, the most commonly used ALS animal model. MNs were cultured together with either non-transgenic or mutant SOD1-G93A astrocyte feeder layers. Cell viability following exposure to kainate as excitotoxic stimulus was assessed by immunocytochemistry and calcium imaging. We then examined the neuroprotective effects of N-acetyl-GLP-1(7-34) amide (N-ac-GLP-1), a long-acting, N-terminally acetylated, C-terminally truncated analog of glucagon-like peptide-1 (GLP-1). GLP-1 has initially been studied as a treatment for type II diabetes based on its function as insulin secretagogue. We detected neuroprotective effects of N-ac-GLP-1 in our in vitro system, which could be attributed to an attenuation of intracellular calcium transients, not only due to these antiexcitotoxic capacities but also with respect to the increasing knowledge about metabolic deficits in ALS which could be positively influenced by N-ac-GLP-1, this compound represents an interesting novel candidate for further in vivo evaluation in ALS.Keywords
This publication has 56 references indexed in Scilit:
- Riluzole neuroprotection in a parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulationBMC Neuroscience, 2012
- Exendin-4 Ameliorates Motor Neuron Degeneration in Cellular and Animal Models of Amyotrophic Lateral SclerosisPLOS ONE, 2012
- Novel GLP‐1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brainJournal of Neuroscience Research, 2011
- Energy metabolism in amyotrophic lateral sclerosisThe Lancet Neurology, 2011
- Interferon-beta treatment normalises the inhibitory effect of serum from multiple sclerosis patients on oligodendrocyte progenitor proliferationNeuroscience Letters, 2010
- Enhancing the GLP‐1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cellsJournal of Neurochemistry, 2010
- Pharmacological Characterization of Human Incretin Receptor Missense VariantsThe Journal of Pharmacology and Experimental Therapeutics, 2010
- GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and ParkinsonismProceedings of the National Academy of Sciences, 2009
- Non–cell autonomous effect of glia on motor neurons in an embryonic stem cell–based ALS modelNature Neuroscience, 2007
- Metabolism and Release of Glutamate in Cerebellar Granule Cells Cocultured with Astrocytes from Cerebellum or Cerebral CortexJournal of Neurochemistry, 1991